Scandalous (Times, £). The drug is Abiraterone, which is freely available in Scotland and Wales. A trial in 2022 showed it would save 672 lives a year if the NHS made it available for a cohort of 8,400 men [J4MB: those with aggressive prostate cancer that had not yet spread] each year. Research also suggests Abiraterone would save the NHS £5,000 a year per patient [J4MB: more than 5x the cost of the drug.] by reducing treatment costs associated with the cancer spreading.
If you’d like email notifications of our new blog pieces, please enter your email address in the box near the top of the right-hand column and click ‘Subscribe’.
We shall shortly be posting this piece on our X channel.
Our YouTube channel is here.
Justice for Men & Boys 
all together now……..
….” if this was for women and they refused to buy it, there would be a national outrage!!!!”
another fine example of two tier UK healthcare ( as Oliver Hardy would say if he were still alive and living in the UK).
I didn’t think the state could descend any further into lunacy….
LikeLiked by 1 person
Its a combination of misandry and ageism. There are few “groups” in society more ignored than older men. It is no surprise that one of the major killers of such men (and one of the most common cancers overall) is cancers of the prostate.
LikeLike
I suppose it does have a logic; reducing the pensions bill.
LikeLike